SEMA3C and central nervous system cancer: High SEMA3C expression is associated with unfavourable outcomes in glioma, breast, lung, liver, pancreatic, gastric, gynecological, and prostate cancers [12,13,14,15,16,17,18,19,20,21,22,23,24,25,26].